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LETTERS
Rickettsia slovaca 
in Dermacentor 
marginatus ticks, 
Germany 
To the Editor: Dermacentor spp. 
ticks are found in many countries in 
Europe, and are vectors for several 
pathogens, including Francisella tu-
larensis, Coxiella burnetii, Rickettsia 
spp., and Babesia canis ( 1,2). Be-
cause Dermacentor marginatus ticks 
require warm dry habitats, these ticks 
are found in only a few areas in south-
ern Germany, mainly in the Rhine and 
Main valleys (3). However, these ticks 
may spread northwards because of in-
creasing temperatures. In contrast, D. 
reticulatus ticks are present through-
out Germany.
Fourteen Rickettsia spp. are cur-
rently identiﬁ  ed as human pathogens. 
The severity of human diseases differs 
among these species, ranging from 
mild to lethal illness (4). On the basis 
of serologic and genotypical charac-
teristics, rickettsiae are divided into ty-
phus and spotted fever groups. Within 
each group, antigenic differences are 
small, resulting in cross-reactivity that 
complicates differentiation of Rickett-
sia spp. by serologic methods. There-
fore, PCR of eschar biopsy samples is 
a useful tool for diagnosis of rickett-
sial diseases (5).
Little information exists regard-
ing the prevalence of Rickettsia spp. 
in  D.  marginatus and D.  reticulatus 
ticks in Germany. R. raoultii was re-
cently detected in 23% of D. reticula-
tus ticks (6). In 1977, Rehacek et al. 
identiﬁ  ed R. slovaca in 12% of Der-
macentor spp. ticks from southern 
Baden-Wuerttemberg (7). Since then, 
this pathogen has not been detected in 
Germany. R. slovaca, a member of the 
spotted fever group, causes tick-borne 
lymphadenopathy, a relatively mild 
rickettsiosis (8). We report detection 
of R. slovaca in 5 of 666 Dermacen-
tor spp. ticks from southern Germany. 
Moreover, we identiﬁ   ed a case of 
tick-borne lymphadenopathy from 
Rhineland-Palatinate.
We collected 666 adult Derma-
centor spp. ticks by blanket-dragging; 
26 were collected along the Main Riv-
er near Aschaffenburg (Bavaria), and 
640 from the Rhine Valley near Lör-
rach (Baden-Wuerttemberg). Ticks 
were homogenized, and the DNA 
was isolated by using the Maxwell 
16 Instrument (Promega, Madison, 
WI, USA). For detection of rickett-
siae, a TaqMan real-time PCR with 
the LightCycler system (Roche Di-
agnostics, Mannheim, Germany) was 
performed according to Wölfel et al. 
(9). A primer pair ampliﬁ  ed a 70-bp 
fragment of the citrate synthase (gltA) 
gene. All positive samples were also 
tested with a PCR speciﬁ  c for the out-
er membrane protein A (rOmpA) gene 
(10). This ampliﬁ   cation yielded an 
rOmpA fragment of 532 bp. Ampliﬁ  ed 
products were analyzed by agarose gel 
electrophoresis.
For identiﬁ  cation  of  Rickettsia 
spp., ampliﬁ   cation products of the 
rOmpA PCR were sequenced by using 
ﬂ  uorescence-labeled  dideoxynucle-
otide technology (Applied Biosys-
tems, Darmstadt, Germany). Separa-
tion of sequenced fragments and data 
collection were performed by using 
an ABI PRISM 310 Genetic Analyzer 
(Applied Biosystems). All obtained se-
quences were analyzed and compared 
by using BLAST (www.ncbi.nlm.nih.
gov/BLAST).
Rickettsia spp. was detected by 
both PCR methods in 31% of 666 
Dermacentor spp. ticks examined. Se-
quencing of part of the rOmpA gene 
showed that sequences of 5 samples 
(0.75%) from Aschaffenburg were 
R. slovaca, showing 100% similarity 
with a sequence deposited in GenBank 
(accession no. U43808). Only D. mar-
ginatus ticks from Aschaffenburg 
were infected with R. slovaca, and 202 
ticks from Lörrach were infected with 
R. raoultii.
We also identiﬁ  ed a case of R. slo-
vaca infection in southern Rhineland-
Palatinate. The patient reported a tick 
bite; the tick was identiﬁ  ed as Der-
macentor spp. Fever, lymphadenopa-
thy of submandibular lymph nodes, 
and exanthema at the site of the tick 
bite developed 7 days later. Serologic 
examinations by using an immuno-
ﬂ   uorescent test (Focus Diagnostics, 
Cypress, CA, USA) showed antibody 
titers of 64 for immunoglobulin (Ig) 
M and 1,024 for IgG against rickett-
siae of the spotted fever group. These 
results indicated an acute rickettsial 
infection. Because of strong cross-
reactivity among all species in the 
spotted fever group, we cannot dif-
ferentiate between antibodies against 
R. slovaca and other species in this 
group.
However, another immunoﬂ  uo-
rescent test for typhus group rick-
ettsiae showed negative results, con-
ﬁ  rming that the patient was infected 
with spotted fever group rickettsiae. 
Results of PCRs speciﬁ  c  for  gltA 
and rOmpA of the patient’s tick were 
positive. We identiﬁ  ed R. slovaca by 
sequencing the rOmpA gene. The se-
quence obtained showed 100% simi-
larity with sequences in ticks from 
Aschaffenburg. Clinical symptoms, 
serologic results, and detection of R. 
slovaca in the tick from the patient 
strongly indicate that the patient had 
tick-borne lymphadenopathy caused 
by R. slovaca.
The high prevalence of R. raoultii 
in Dermacentor spp. ticks is of con-
cern because this species can also 
cause tick-borne lymphadenopathy, 
although R. raoultii is less pathogenic 
than R. slovaca (8). Tick-borne lymph-
adenopathy should be considered in 
the differential diagnosis of tick-borne 
diseases. The extent of the distribution 
of R. slovaca and R. raoultii in Ger-
many remains to be elucidated.
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